DIAbetes and diffuse coronary Narrowing Analysis Study.
Phase of Trial: Phase III
Latest Information Update: 12 Jan 2012
At a glance
- Drugs Nateglinide (Primary) ; Voglibose (Primary)
- Indications Coronary artery disease; Glucose intolerance; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIANA
- 26 Mar 2010 New trial record
- 15 Mar 2010 Results presented at the 59th Annual Scientific Session of the American College of Cardiology (ACC 2010).